Contemporary accuracy of death certificates for coding prostate cancer as a cause of death: Is reliance on death certification good enough? A comparison with blinded review by an independent cause of death evaluation committee
- PMID: 27253172
- PMCID: PMC4931376
- DOI: 10.1038/bjc.2016.162
Contemporary accuracy of death certificates for coding prostate cancer as a cause of death: Is reliance on death certification good enough? A comparison with blinded review by an independent cause of death evaluation committee
Abstract
Background: Accurate cause of death assignment is crucial for prostate cancer epidemiology and trials reporting prostate cancer-specific mortality outcomes.
Methods: We compared death certificate information with independent cause of death evaluation by an expert committee within a prostate cancer trial (2002-2015).
Results: Of 1236 deaths assessed, expert committee evaluation attributed 523 (42%) to prostate cancer, agreeing with death certificate cause of death in 1134 cases (92%, 95% CI: 90%, 93%). The sensitivity of death certificates in identifying prostate cancer deaths as classified by the committee was 91% (95% CI: 89%, 94%); specificity was 92% (95% CI: 90%, 94%). Sensitivity and specificity were lower where death occurred within 1 year of diagnosis, and where there was another primary cancer diagnosis.
Conclusions: UK death certificates accurately identify cause of death in men with prostate cancer, supporting their use in routine statistics. Possible differential misattribution by trial arm supports independent evaluation in randomised trials.
Figures
Similar articles
-
Assessment of causes of death in a prostate cancer screening trial.Int J Cancer. 2008 Jan 15;122(2):413-7. doi: 10.1002/ijc.23126. Int J Cancer. 2008. PMID: 17935123
-
High accuracy of Swedish death certificates in men participating in screening for prostate cancer: a comparative study of official death certificates with a cause of death committee using a standardized algorithm.Scand J Urol Nephrol. 2011 Sep;45(4):226-32. doi: 10.3109/00365599.2011.559950. Epub 2011 Apr 5. Scand J Urol Nephrol. 2011. PMID: 21463227
-
High Norwegian prostate cancer mortality: evidence of over-reporting.Scand J Urol. 2018 Apr;52(2):122-128. doi: 10.1080/21681805.2017.1421260. Epub 2018 Jan 11. Scand J Urol. 2018. PMID: 29325479
-
Radical prostatectomy versus deferred treatment for localised prostate cancer.Cochrane Database Syst Rev. 2020 Jun 4;6(6):CD006590. doi: 10.1002/14651858.CD006590.pub3. Cochrane Database Syst Rev. 2020. PMID: 32495338 Free PMC article.
-
Changes in and Impact of the Death Review Process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.Rev Recent Clin Trials. 2015;10(3):206-11. doi: 10.2174/1574887110666150730120752. Rev Recent Clin Trials. 2015. PMID: 26238119 Review.
Cited by
-
Comparison of Minimally Invasive Tissue Sampling With Conventional Autopsy to Detect Pulmonary Pathology Among Respiratory Deaths in a Resource-Limited Setting.Am J Clin Pathol. 2019 Jun 5;152(1):36-49. doi: 10.1093/ajcp/aqz016. Am J Clin Pathol. 2019. PMID: 31006817 Free PMC article.
-
Assessing the Cause of Death for Men with Prostate Cancer Using Official Mortality Statistics or a Dedicated Cause of Death Committee: Results from 30-year ERSPC Rotterdam Data.Eur Urol Open Sci. 2024 Nov 16;71:11-14. doi: 10.1016/j.euros.2024.10.021. eCollection 2025 Jan. Eur Urol Open Sci. 2024. PMID: 39641118 Free PMC article.
-
Vasectomy and Prostate Cancer Risk in the European Prospective Investigation Into Cancer and Nutrition (EPIC).J Clin Oncol. 2017 Apr 20;35(12):1297-1303. doi: 10.1200/JCO.2016.70.0062. Epub 2017 Mar 6. J Clin Oncol. 2017. PMID: 28375714 Free PMC article.
-
Individual prognosis at diagnosis in nonmetastatic prostate cancer: Development and external validation of the PREDICT Prostate multivariable model.PLoS Med. 2019 Mar 12;16(3):e1002758. doi: 10.1371/journal.pmed.1002758. eCollection 2019 Mar. PLoS Med. 2019. PMID: 30860997 Free PMC article.
-
Mortality from leading cancers in districts of England from 2002 to 2019: a population-based, spatiotemporal study.Lancet Oncol. 2024 Jan;25(1):86-98. doi: 10.1016/S1470-2045(23)00530-2. Epub 2023 Dec 11. Lancet Oncol. 2024. PMID: 38096890 Free PMC article.
References
-
- Albertsen PC, Walters S, Hanley JA (2000) A comparison of cause of death determination in men previously diagnosed with prostate cancer who died in 1985 or 1995. J Urol 163: 519–523. - PubMed
-
- Barry MJ, Andriole GL, Culkin DJ, Fox SH, Jones KM, Carlyle MH, Wilt TJ (2013) Ascertaining cause of death among men in the prostate cancer intervention versus observation trial. Clin Trials 10: 907–914. - PubMed
-
- Black WC, Haggstrom DA, Welch HG (2002) All-cause mortality in randomized trials of cancer screening. J Natl Cancer Inst 94: 167–173. - PubMed
-
- Clopper CJ, Pearson ES (1934) The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 26: 404–413.
-
- de Koning HJ, Blom J, Merkelbach JW, Raaijmakers R, Verhaegen H, Van VP, Nelen V, Coebergh JW, Hermans A, Ciatto S, Makinen T (2003) Determining the cause of death in randomized screening trial(s) for prostate cancer. BJU Int 92(Suppl 2): 71–78. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical